Novartis Sues Bayer Over Hemophilia Drug Patent

Law360, New York (February 20, 2008, 12:00 AM EST) -- Swiss drugmaker Novartis AG has sued Bayer AG and its U.S. subsidiary for infringement over the German company's drug Kogenate, a medicine used to treat hemophilia.

Novartis' California-based vaccines and diagnostics division, Novartis Vaccines and Diagnostics Inc., and Danish drugmaker Novo Nordisk A/S filed the suit in the U.S District Court for the Eastern District of Texas on Friday. Also named in the suit is Pennsylvania-based CSL Behring, which makes the antihemophilic drug Helixate.

Novartis and Novo Nordisk are seeking treble damages in the suit, which...
To view the full article, register now.